Symbol | Exchange | Currency |
|---|
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 320.00 | 322.50 | 314.50 | 0.00 | 0.00% | 755.58K | London | |||
| 428.70 | 431.40 | 422.30 | -0.50 | -0.12% | 10.78M | London | |||
| 1,766.00 | 1,804.50 | 1,702.00 | -150.50 | -7.85% | 9.72M | London | |||
| 1.68 | 2.02 | 0.52 | 0.00 | 0.00% | 0.00 | London | |||
| 44.80 | 45.85 | 44.70 | -1.70 | -3.66% | 522.12K | London | |||
| 518.90 | 522.20 | 494.75 | +17.90 | +3.57% | 63.72M | London | |||
| 2,151.00 | 2,162.00 | 2,124.00 | +5.0 | +0.23% | 1.64M | London | |||
| 3,628.50 | 3,654.00 | 3,596.50 | -24.0 | -0.66% | 2.10M | London | |||
| 693.20 | 738.00 | 693.20 | -48.00 | -6.48% | 4.48M | London | |||
| 181.25 | 181.75 | 181.25 | 0.00 | 0.00% | 0.00 | London | |||
| 1,605.00 | 1,638.00 | 1,597.00 | -23.0 | -1.41% | 1.20M | London | |||
| 70.74 | 72.78 | 70.02 | -3.62 | -4.87% | 17.12M | London | |||
| 829.40 | 863.60 | 828.80 | -43.40 | -4.97% | 1.66M | London | |||
| 1.15 | 1.15 | 1.15 | -0.1500 | -11.77% | 301.21M | London | |||
| 295.40 | 303.70 | 291.90 | -4.30 | -1.44% | 354.24K | London |